Overview

Atorvastatin in the TREATment of Intracranial Unruptured VertebroBasilar Dissecting Aneurysms

Status:
Not yet recruiting
Trial end date:
2022-07-30
Target enrollment:
Participant gender:
Summary
This study was designed to whether there is a measurable reduction in inflammation in walls of unruptured vertebrobasilar dissecting aneurysms with atorvastatin.
Phase:
N/A
Details
Lead Sponsor:
Beijing Neurosurgical Institute
Treatments:
Atorvastatin